Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/10/2014US8748468 Manufacture, compositions and uses of coagulation factor VIIa modulator
06/10/2014US8748467 Topical formulation
06/10/2014US8748465 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
06/10/2014US8748464 Use of SIRT1 activators or inhibitors to modulate an immune response
06/10/2014US8748463 Histone deacetylase inhibitors and methods of use thereof
06/10/2014US8748462 Spirocyclic GPR40 modulators
06/10/2014US8748461 Metalloenzyme inhibitor compounds
06/10/2014US8748460 Iminosugars and methods of treating togaviral diseases
06/10/2014US8748459 Pyridinoylpiperidines as 5-HT1F agonists
06/10/2014US8748458 Scriptaid isosteres and their use in therapy
06/10/2014US8748457 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent DPP-IV inhibitors
06/10/2014US8748456 Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
06/10/2014US8748455 Solid forms of a pharmaceutically active substance
06/10/2014US8748454 Anti-constipation composition
06/10/2014US8748453 Substituted heterocyclic compounds as kinases inhibitors and methods of use thereof
06/10/2014US8748452 Indolizine derivative and use thereof for medical purposes
06/10/2014US8748451 HDAC inhibitors and therapeutic methods of using same
06/10/2014US8748450 Morphinan compounds
06/10/2014US8748449 Use of polyols to obtain stable polymorphous forms of rifaximin
06/10/2014US8748448 Combination analgesic employing opioid agonist and neutral antagonist
06/10/2014US8748447 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
06/10/2014US8748446 Halogenated compounds for photodynamic therapy
06/10/2014US8748445 Methods for treating glioma
06/10/2014US8748443 Antiviral compounds and uses thereof
06/10/2014US8748442 sGC stimulators
06/10/2014US8748441 Therapeutic uses of quinazolinedione derivatives
06/10/2014US8748440 Quinazolinone modulators of nuclear receptors
06/10/2014US8748439 Inhibitors of Bruton's tyrosine kinase
06/10/2014US8748438 Inhibitors of Bruton's tyrosine kinase
06/10/2014US8748437 Crystal of 2-(3,4 dichlorobenzyl)-5-methyl-4-oxo-3,4-dihydrothien[2,3-D]pyrimidine-6-carboxylic acid
06/10/2014US8748436 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
06/10/2014US8748435 Pyrazolo pyrimidine derivatives
06/10/2014US8748433 β3 adrenergic receptor agonists
06/10/2014US8748432 Microbiocidal pyrazole derivatives
06/10/2014US8748431 Microbicidal heterocycles
06/10/2014US8748430 Pyrrolidin-3yl-methylamine quinoxaline derivatives
06/10/2014US8748429 CGRP receptor antagonists
06/10/2014US8748428 Use of a PKC inhibitor
06/10/2014US8748426 Inhibitors of diacylglycerol acyl transferase
06/10/2014US8748425 Combination of brimonidine and timolol for topical ophthalmic use
06/10/2014US8748423 Compositions and methods for the prevention and treatment of cancer
06/10/2014US8748422 Pharmaceutical compositions containing quinazoline derivatives for treating as serotonin receptor antagonist
06/10/2014US8748421 Triazine compounds as P13 kinase and MTOR inhibitors
06/10/2014US8748420 Pyridinylcarboxylic acid derivatives as fungicides
06/10/2014US8748419 Treating obesity with muscarinic receptor M1 antagonists
06/10/2014US8748418 1,4-oxazepines as BACE1 and/or BACE2 inhibitors
06/10/2014US8748417 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
06/10/2014US8748416 Opioid salts and formulations exhibiting anti-abuse and anti-dumping properties
06/10/2014US8748415 C-28 amines of C-3 modified betulinic acid derivatives as HIV maturation inhibitors
06/10/2014US8748414 Statin nanoparticles
06/10/2014US8748413 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
06/10/2014US8748412 Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators
06/10/2014US8748411 Antineoplastic compounds and pharmaceutical compositions thereof
06/10/2014US8748410 Methods of treating aneurysm
06/10/2014US8748409 Polysaccharide derivative and hydrogel thereof
06/10/2014US8748408 Methods of treatment of mitochondrial disorders
06/10/2014US8748406 Preventive for adhesion following abdominal surgery
06/10/2014US8748402 Ophthalmic formulations and uses thereof
06/10/2014US8748401 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
06/10/2014US8748400 Use of ketogenic compounds for treatment of age-associated memory impairment
06/10/2014US8748397 Lyophilization of synthetic liposomal pulmonary surfactant
06/10/2014US8748396 Lyophilization of synthetic liposomal pulmonary surfactant
06/10/2014US8748391 β-turn peptidomimetic cyclic compounds for treating dry eye
06/10/2014US8748388 Antitumoral compounds
06/10/2014US8748369 Use of targeted nitroxide agents in bone healing
06/10/2014US8748347 Method for combating harmful fungi
06/10/2014US8748340 Pesticidal compositions and processes related thereto
06/10/2014US8748105 Method for selecting a candidate drug compound
06/10/2014US8747924 Methods for preventing and treating neurodegenerative diseases
06/10/2014US8747920 Pharmaceutical compositions comprising non-steroidal antiinflammatory drug, antipyretic-analgesic drug and proton pump inhibitor
06/10/2014US8747912 Drug delivery system
06/10/2014US8747910 Prediction of response to platinum-based therapy
06/10/2014US8747904 Polymeric micelles for polynucleotide encapsulation
06/10/2014US8747903 Composition for nucleic acid delivery using metal nanoparticles and preparing method thereof
06/10/2014US8747900 Dosage form with improved release of cefuroximaxetil
06/10/2014US8747898 Controlled release oral dosage form
06/10/2014US8747896 Mucosal bioadhesive slow release carrier for delivering active principles
06/10/2014US8747894 Effervescent compositions containing N-acetylcysteine
06/10/2014US8747891 Ceramide anionic liposome compositions
06/10/2014US8747889 Transdermal analgesic systems with reduced abuse potential
06/10/2014US8747886 Nanoimprinting of silk fibroin structures for biomedical and biophotonic applications
06/10/2014US8747883 Medical item for long term drug release
06/10/2014US8747874 Spray oil and method of use thereof for controlling turfgrass pests
06/10/2014US8747844 Methods of treating pain
06/10/2014US8747837 Oncolytic vaccinia virus combination cancer therapy
06/10/2014US8747832 Biodegradable polyanhydrides with natural bioactive molecules
06/10/2014US8747831 Method and antibacterial/antimicrobial compositions in dental compositions
06/10/2014US8747830 Wound repair composition and method
06/10/2014US8747829 Presbyopia treatment by lens alteration of disulfide bonds and reduction
06/10/2014US8747827 Emulsified cosmetic composition
06/10/2014US8747817 System and method of complementary day/night children's skin cream compositions
06/10/2014US8747815 Use of a cosmetic of pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins
06/10/2014US8747813 Inhalable epinephrine
06/10/2014CA2803995C Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
06/10/2014CA2795080C Purine compounds
06/10/2014CA2784799C Certain dipeptidyl peptidase inhibtors
06/10/2014CA2777664C Macrocyclic integrase inhibitors
06/10/2014CA2771189C Novel dihydro-oxazolobenzodiazepinon derivatives, processes for their preparation and pharmaceutical compositions containing them
06/10/2014CA2764906C Gpr119 agonists
06/10/2014CA2721815C Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same